Chad Kolean Named CFO
What is nanoLOCK® Surface Technology?
Shortly after launching our original surface in 2007 and witnessing how well patients were responding to our technology, we challenged ourselves to make it even better. We began working with some of the brightest minds in biomaterial sciences to investigate ways to improve the bone formation response to our implants. The result? nanoLOCK® surface technology, which has been proven to upregulate a significantly greater amount of bone growth factors than even our original surface.1
How did we do that? By incorporating a significantly greater amount of the microscopic and nanoscopic features that are found on natural bone.2 That means the body “sees” the implant surface as being conducive to bone growth and begins the process virtually from the moment the device is implanted.3
nanoLOCK® is the first and only FDA-cleared nanotechnology device for the spine. And it is the only technology with access to the CMS new technology code for nanotextured interbody devices. It is the recipient of several awards, including the prestigious Whitecloud Award for best basic science, and has been used as an example of commercialized nanotechnology success in medicine by the White House Office of Science and Technology as part of the National Nanotechnology Initiative. nanoLOCK® has been published in five peer-reviewed publications and was commercially launched in August of 2016.
Oh, and did we mention that it is guaranteed to fuse?
- Oltvares-Navarrete, R., Hyzy S.L., Gittens, R.A., Berg, M.E., Schneider, J.M., Hotchkiss, K., Schwartz, Z., Boyan, B. D. Osteoblast lineage cells can discriminate microscale topographic features on titanium-aluminum-vanadium surfaces. Ann Biomed Eng. 2014 Dec; 42 (12): 2551-61.
- Matteson JL, Greenspan DC, Tighe TB, et al. Assessing the hierarchical structure of titanium implant surfaces. Journal of Biomedical Materials Research Part B Applied Biomaterials 104(6). May 2015. DOI:10.1002/jbm.b.33462.
- Data on file.